Literature DB >> 21975127

Multiple organ inflammatory response to portosystemic shunt in the rat.

Cruz García1, Elena Gine, María-Angeles Aller, Elena Revuelta, Jorge-Luis Arias, Elena Vara, Jaime Arias.   

Abstract

Portosystemic shunt surgery is the best procedure to prevent recurrent bleeding of esophageal varices, but carries a high risk of postoperative inflammatory complications, including hepatic encephalopathy. Thus, portosystemic shunting procedures could induce a systemic inflammatory response with multiple organ dysfunction syndrome, including hepatic encephalopathy. To verify this hypothesis we used male Wistar rats at 6 weeks of postoperative evolution: Control (CR; n=14), Sham-operated (SO; n=8) and rats with end-to-side portacaval shunt (PCS; n=15). TNF-α, IL-1β and IL-10 were assayed by ELISA techniques, the expression of the endothelial constitutive nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), constitutive and inducible heme-oxygenase (HO-1 and HO-2) were assayed by Western-blot. mRNA levels of HO-1, HO-2, TNF-α, IL-1β and IL-10 were quantified by reverse transcriptase polymerase chain reaction amplification (RT-PCR) in the small bowel, liver, spleen and lungs. Portacaval shunting in the rat produces an interorgan imbalance of pro- and anti-inflammatory mediators. TNF-α mRNA expression is decreased in the liver (0.69±0.28, p<0.05). The hepatic production of IL-Iβ (204.13±71.90 pg/100 g; p<0.001) and IL-10 (4505.47±337.97 pg/100 g; p<0.001) is also decreased. However, the intestinal pro-inflammatory (TNF-α: 1471.86±153.62 pg/100 g, p<0.001; IL-1β: 48.35±9.84 pg/100 g, p<0.001 and iNOS: 0.59±0.01, p<0.01) and anti-inflammatory (IL-10: 1503.39±53.5 pg/100 g, p<0.001 and HO-1: 2.23±0.16, p<0.001) mediators are increased. Total portacaval shunting in the rat induces impairments of pro- and anti-inflammatory mediators in the splanchnic-lung axis that could be associated with a multiple organ dysfunction syndrome. Therefore, the complications after portosystemic shunts could be integrated into a systemic inflammatory response of possible intestinal origin.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21975127     DOI: 10.1016/j.cyto.2011.08.033

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  4 in total

1.  Loss of Nrf2 in mice evokes a congenital intrahepatic shunt that alters hepatic oxygen and protein expression gradients and toxicity.

Authors:  John J Skoko; Nobunao Wakabayashi; Kentaro Noda; Shoko Kimura; Kimimasa Tobita; Norihisa Shigemura; Tadayuki Tsujita; Masayuki Yamamoto; Thomas W Kensler
Journal:  Toxicol Sci       Date:  2014-06-12       Impact factor: 4.849

2.  Hepatic proliferation and angiogenesis markers are increased after portal deprivation in rats: a study of molecular, histological and radiological changes.

Authors:  Florent Guérin; Mathilde Wagner; Antoine Liné; Magaly Zappa; Magali Fasseu; Valérie Paradis; Valérie Vilgrain; Bernard E Van Beers; Josette Legagneux; Richard Moreau; Philippe Lettéron
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

3.  Recovery from Liver Failure and Fibrosis in a Rat Portacaval Anastomosis Model after Neurointermediate Pituitary Lobectomy.

Authors:  Martín Muñoz-Ortega; Noé Macías-Segura; Javier Ventura-Juárez; Manuel Enrique Ávila-Blanco; Leonardo D Ponce-Damian; Daniel González-Blas; Esperanza Sánchez-Alemán; Andrés Quintanar-Stephano
Journal:  J Immunol Res       Date:  2021-12-09       Impact factor: 4.818

4.  The C57BL/6J mouse exhibits sporadic congenital portosystemic shunts.

Authors:  Cristina Cudalbu; Valérie A McLin; Hongxia Lei; Joao M N Duarte; Anne-Laure Rougemont; Graziano Oldani; Sylvain Terraz; Christian Toso; Rolf Gruetter
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.